IMCAS

SHANGHAI MAY SKIN - AI for Aesthetic Growth: How Skin Analysis Drives Precision Treatment and Clinic High Conversion

DIOR - The reverse Aging science for beauty

Objectives: Dior puts the science of Reverse Aging at the service of beauty to accelerate research and development of skincare products.

Introduction: If healthy longevity is the ultimate goal, the pathways of Reverse Aging are unanimously recognized by scientific experts as essential players in the aging process.

Results: In this context, Chronic inflammation that we call Skin inflammaging, is one of the 12 hallmarks of aging and it has been addressed for over 20 years by Dior Prestige to rejuvenate the skin in a very efficient manner and is interdependent with the intercellular communication.

Conclusion: This interconnection leads to the discovery of biological pathways on which new extracts from Rose de Granville will act intensely and profoundly to achieve accelerated regeneration.

Divulgação de informações

Você recebeu algum patrocínio para sua pesquisa neste tema?
Não

Você recebeu algum tipo de honorário, pagamento ou outra forma de compensação por seu trabalho neste estudo?
Não

Você possui relação financeira com alguma entidade que possa competir com os medicamentos, materiais ou instrumentos abordados no seu estudo?
Não

Você detém ou pediu a registro de patente para algum dos instrumentos, medicamentos ou materiais abordados no seu estudo?
Não

Este trabalho não recebeu nenhum patrocínio direto ou indireto. O mesmo está sob a própria responsabilidade do seu autor.

LOTOS UNITED - Hybrid treatment protocols in different morphotypes of facial ageing: PLLA and HA fillers

Objectives: This presentation will focus on treatment protocols and techniques for the combined use of HA fillers and PLLA, tailored to different facial aging morphotypes. It will explore product selection, injection strategies, and procedural nuances to achieve natural and harmonious rejuvenation.

Introduction: The combined use of hyaluronic acid (HA) fillers and poly-L-lactic acid (PLLA) presents a promising approach to addressing anatomical disproportions and age-related changes. Traditionally, these products are applied separately in distinct anatomical zones and tissue layers; however, integrating them within a single treatment session can enhance results, providing optimal and long-lasting outcomes.

Divulgação de informações

Você recebeu algum patrocínio para sua pesquisa neste tema?
Não

Você recebeu algum tipo de honorário, pagamento ou outra forma de compensação por seu trabalho neste estudo?
Não

Você possui relação financeira com alguma entidade que possa competir com os medicamentos, materiais ou instrumentos abordados no seu estudo?
Sim
Por favor indique a entidade (pessoa ou empresa): Lotos United

Você detém ou pediu a registro de patente para algum dos instrumentos, medicamentos ou materiais abordados no seu estudo?
Não

Este trabalho foi realizado com o patrocínio de: Lotos United

Doctor IP in action: from 13 years of clinical practice to building a medical aesthetics brand ecosystem - Asian skin, anti-aging, and online penetration

Objectives: This course will provide participants with a comprehensive understanding of the core elements and strategies for integrating physician intellectual property (IP) development with clinical device applications. Participants will learn to establish an effective system for personal brand building and clinical technology application.

Introduction: In today's rapidly developing medical aesthetics industry, building a doctor's personal brand has become a key way to increase industry influence and commercial value. This report aims to deeply explore practical strategies for integrating doctor IP with clinical devices. Through case studies of successful IP development, the report reveals how to leverage clinical experience, academic achievements, online traffic management, and brand collaborations to create an IP with an international perspective.

Materials / method: First, to successfully build a doctor's IP, it is necessary to lay a solid professional foundation. Next, focus on online operational strategies and establish a data-driven mindset. Regularly analyze platform data, patient feedback, and market trends to optimize content strategies and commercial cooperation models continuously. By following a systematic IP development path, doctors can enhance their personal brand influence and drive the innovative application of medical technology, ultimately achieving dual enhancement of their professional and commercial value.

Results: Doctors can develop a clear roadmap for their IP development by clearly defining the positioning, model, and team and resource integration of medical aesthetics care companies. Each step must be carefully planned and steadily implemented, from the short-term deepening of the Asian skin database and incubation of a doctor IP matrix to the mid-term launch of co-branded care lines and establishment of an online and offline service network, and finally to the long-term goal of becoming the standard-setter for Asian skin anti-aging and promoting the globalization of medical IP.

Conclusion: Developing a doctor IP requires a systematic approach that focuses on four core elements: clinical experience, brand partnerships, online traffic management, and the latest clinical data. With continuous effort and innovation, a doctor IP's professionalism, commercial value, and market influence can be enhanced.

Divulgação de informações

Você recebeu algum patrocínio para sua pesquisa neste tema?
Não

Você recebeu algum tipo de honorário, pagamento ou outra forma de compensação por seu trabalho neste estudo?
Não

Você possui relação financeira com alguma entidade que possa competir com os medicamentos, materiais ou instrumentos abordados no seu estudo?
Não

Você detém ou pediu a registro de patente para algum dos instrumentos, medicamentos ou materiais abordados no seu estudo?
Não

Este trabalho não recebeu nenhum patrocínio direto ou indireto. O mesmo está sob a própria responsabilidade do seu autor.

VINNO - Ultrasound Aesthetic Solutions

OBAGI - Research Progress on Melasma

OBAGI - Sharing of Combination Treatment Strategies for Melasma with Topical Obagi Hydroquinone and Vitamin C Preparations

GE HEALTHCARE - Vscan Air™ launches a new era of visual aesthetics

LOTOS UNITED - The potential of PLLA and uncrosslinked HA in collagen stimulation programs

Objectives: In the present study, we are aimed at creating a hybrid protocol, combining the application injectable poly-L-lactic acid and hyaluronic acid. The protocol has to meet the requirements safety, effecacy, and predictability of clinical results.

Introduction: There are pathological conditions, including scars and striae, as well as normal physiological processes, such as aging, associated with changes in the quality and quantity of collagen fibres in the skin. The possibility of predictable bioregulation of new collagen fibres production is a challenge that both manufacturers of collagen stimulators and dermatologists face whit.

Materials / method: Poly-L-lactic acid and uncrosslinked high molecular weight hyaluronic acid were injected in one zone, at one level, to a certain depth and within one treatment session. Dynamic monitoring was conducted for 6 weeks. Ultrasound study and histological examination of skin biopsies were used to estimate the result of the treatment.

Results: We revealed a common trend including reduction in rehabilitation period and achievement of positive clinical results witch took less time in comparison with the patients who were treated with according to a mono protocol eather whit poly-l-lactic acid or hyaluronic acid . The treatment with a combined protocol allowed as to reduce the number of patients’s visits to the clinic and to get a high level of patients’s satisfaction.

Conclusion: Hybrid protocols combining the application of injectable poly-L-lactic acid and hyaluronic acid are characterized by safety and hight predictable performance.

Divulgação de informações

Você recebeu algum patrocínio para sua pesquisa neste tema?
Sim
Por favor indique a entidade (pessoa ou empresa): LOTOS UNITED

Você recebeu algum tipo de honorário, pagamento ou outra forma de compensação por seu trabalho neste estudo?
Sim
Por favor indique a entidade (pessoa ou empresa): LOTOS UNITED

Você possui relação financeira com alguma entidade que possa competir com os medicamentos, materiais ou instrumentos abordados no seu estudo?
Não

Você detém ou pediu a registro de patente para algum dos instrumentos, medicamentos ou materiais abordados no seu estudo?
Não

Este trabalho foi realizado com o patrocínio de: LOTOS UNITED

LOTOS UNITED - The reasonable approach of combination EBDs and PLLA in aesthetic medicine

FIMAN BIOTECHNOLOGY - The Renaissance of Animal-Derived Collagen Fillers in China: A Perfect Storm of Innovation and Demand

LABORATOIRES VIVACY - Yield stress and plastic domain as innovative rheological parameters for characterization of crosslinked hyaluronic acid hydrogels and clinical application potential

Horas	Palestrantes	Título da apresentação	Resumo	Número
11:00	Fabin SHEN	SHANGHAI MAY SKIN - AI for Aesthetic Growth: How Skin Analysis Drives Precision Treatment and Clinic High Conversion		147858
11:15	Virginie COUTURAUD	DIOR - The reverse Aging science for beauty	Visualizar	147859
11:30	Dr Elena RAZUMOVSKAYA	LOTOS UNITED - Hybrid treatment protocols in different morphotypes of facial ageing: PLLA and HA fillers	Visualizar	147860
11:45	Dr Wenhui CHEN	Doctor IP in action: from 13 years of clinical practice to building a medical aesthetics brand ecosystem - Asian skin, anti-aging, and online penetration	Visualizar	147861
12:00	Yuan TIAN	VINNO - Ultrasound Aesthetic Solutions		147862
13:45	Prof Gaoyun YANG	OBAGI - Research Progress on Melasma		147869
14:00	Prof Gaoyun YANG	OBAGI - Sharing of Combination Treatment Strategies for Melasma with Topical Obagi Hydroquinone and Vitamin C Preparations		147870
14:15	Hualong YU	GE HEALTHCARE - Vscan Air™ launches a new era of visual aesthetics		147871
14:30	Prof Olga KAPULER	LOTOS UNITED - The potential of PLLA and uncrosslinked HA in collagen stimulation programs	Visualizar	147872
14:45	Dr Natalia KALASHNIKOVA	LOTOS UNITED - The reasonable approach of combination EBDs and PLLA in aesthetic medicine		147873
15:00	Dr Qing ZHAO	FIMAN BIOTECHNOLOGY - The Renaissance of Animal-Derived Collagen Fillers in China: A Perfect Storm of Innovation and Demand		147874
15:15	Di ZONG	LABORATOIRES VIVACY - Yield stress and plastic domain as innovative rheological parameters for characterization of crosslinked hyaluronic acid hydrogels and clinical application potential		147875
15:30	Lei HAN	UNILEVER - Beauty and Wellbeing Science and Technology		147876
15:45	Xuelan GU	UNILEVER - Pioneering Research Revealing the Importance of Stress in Relation to Skin and Hair Well-being		147877
16:00	Dr Chengfeng ZHANG	UNILEVER - The Power of Multi-Vitamin to Restore the Stressed Skin and Aging		147878
16:15	Dr Fengjuan TU	UNILEVER - ExoBooster: Lactobacillus Exosomes for Skin-rejuvenating		147879

IMCAS China 2025
Programa

Industry sponsored lectures

Apresentações desta sessão

IMCAS China 2025 Programa

Industry sponsored lectures

Apresentações desta sessão

IMCAS China 2025
Programa